Literature DB >> 11328385

The role of hepatocyte growth factor and its receptor c-met in interactions between lymphocytes and stromal cells in secondary human lymphoid organs.

G Skibinski1, A Skibinska, K James.   

Abstract

Secondary lymphoid tissue consists of two major populations of cells: lymphoid cells and stromal cells. It is generally accepted that these two cell populations influence each other however, factors mediating these processes are poorly understood. In this paper we characterize one of the possible means of communication between stroma and lymphocytes namely through hepatocyte growth factor/c-met receptor interactions. Hepatocyte growth factor (HGF) is a pleiotropic factor that is mainly produced by mesenchymal cells and acts on cells of epithelial origin which express the HGF receptor c-met. Here we demonstrate that biologically active HGF is constitutively produced by fibroblast-like stromal cells from human lymphoid tissues. HGF secretion from stromal cells was increased by direct contact with activated T cells. This increase was abrogated when activated T cells were separated physically from stromal cells. Using neutralizing antibody or cytokine inhibitors we provide evidence that enhancement of HGF production was due to additive effects of T-cell membrane-associated interleukin-1 (IL-1) and CD40 ligand. Finally, we also show that B lymphocytes activated with CD40L/anti-mu or phorbol 12-myristate 13-acetate (PMA) express c-met receptor. Co-culture of activated B cells with stromal cells from spleen leads to enhanced production of immunoglobulins. This can be partially inhibited by introduction of anti-HGF neutralizing antibodies to the culture system. Substitution of stromal cells with recombinant HGF did not produce enhancement of immunoglobulin secretion. On the other hand stimulation of c-met receptor with HGF leads to enhanced integrin-mediated adhesion of activated B cells to vascular cell adhesion molecule (VCAM-1) and fibronectin. On the basis of the above experiments we conclude that HGF production by fibroblast-like stromal cells can be modulated by activated T cells, thus providing signals for the regulation of adhesion of c-met expressing B cells to extracellular matrix proteins. In this way HGF may indirectly influence immunoglobulin secretion by B cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11328385      PMCID: PMC1783204          DOI: 10.1046/j.1365-2567.2001.01186.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  31 in total

Review 1.  Integrins: versatility, modulation, and signaling in cell adhesion.

Authors:  R O Hynes
Journal:  Cell       Date:  1992-04-03       Impact factor: 41.582

Review 2.  The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death.

Authors:  C A Smith; T Farrah; R G Goodwin
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

3.  Expression and function of surface antigens on scleroderma fibroblasts.

Authors:  D Abraham; S Lupoli; A McWhirter; C Plater-Zyberk; T H Piela; J H Korn; I Olsen; C Black
Journal:  Arthritis Rheum       Date:  1991-09

4.  Synergistic effect of interleukin-1 and CD40L on the activation of human renal tubular epithelial cells.

Authors:  C van Kooten; X van der Linde; A M Woltman; L A van Es; M R Daha
Journal:  Kidney Int       Date:  1999-07       Impact factor: 10.612

5.  Isolation, culture, and transplantation of human hepatocytes.

Authors:  S C Strom; R L Jirtle; R S Jones; D L Novicki; M R Rosenberg; A Novotny; G Irons; J R McLain; G Michalopoulos
Journal:  J Natl Cancer Inst       Date:  1982-05       Impact factor: 13.506

6.  The integrin subunits alpha 2, alpha 3, alpha 4, alpha 5, alpha 6, alpha V, beta 1 and beta 3 in fetal, infant and adult human spleen as detected by immunohistochemistry.

Authors:  K A Liakka
Journal:  Differentiation       Date:  1994-05       Impact factor: 3.880

7.  Cytokine network regulating terminal maturation of human bone marrow B cells capable of spontaneous and high rate Ig secretion in vitro.

Authors:  E Roldán; C Rodriguez; G Navas; C Parra; J A Brieva
Journal:  J Immunol       Date:  1992-10-01       Impact factor: 5.422

8.  Hepatocyte growth factor enhances B-cell activity.

Authors:  B Delaney; W S Koh; K H Yang; S C Strom; N E Kaminski
Journal:  Life Sci       Date:  1993       Impact factor: 5.037

9.  CD40 is functionally expressed on human thymic epithelial cells.

Authors:  A H Galy; H Spits
Journal:  J Immunol       Date:  1992-08-01       Impact factor: 5.422

10.  Hepatocyte growth factor and macrophage inflammatory protein 1 beta: structurally distinct cytokines that induce rapid cytoskeletal changes and subset-preferential migration in T cells.

Authors:  D H Adams; L Harvath; D P Bottaro; R Interrante; G Catalano; Y Tanaka; A Strain; S G Hubscher; S Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

View more
  19 in total

1.  Reduced T cell-dependent humoral immune response in microsomal prostaglandin E synthase-1 null mice is mediated by nonhematopoietic cells.

Authors:  Fumiaki Kojima; Andrey Frolov; Rahul Matnani; Jerold G Woodward; Leslie J Crofford
Journal:  J Immunol       Date:  2013-10-14       Impact factor: 5.422

2.  Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages.

Authors:  Paolo Giannoni; Gabriella Pietra; Giorgia Travaini; Rodolfo Quarto; Genti Shyti; Roberto Benelli; Laura Ottaggio; Maria Cristina Mingari; Simona Zupo; Giovanna Cutrona; Ivana Pierri; Enrico Balleari; Alessandra Pattarozzi; Marco Calvaruso; Claudio Tripodo; Manlio Ferrarini; Daniela de Totero
Journal:  Haematologica       Date:  2014-02-21       Impact factor: 9.941

3.  An interaction between hepatocyte growth factor and its receptor (c-MET) prolongs the survival of chronic lymphocytic leukemic cells through STAT3 phosphorylation: a potential role of mesenchymal cells in the disease.

Authors:  Paolo Giannoni; Silvia Scaglione; Rodolfo Quarto; Roberto Narcisi; Manuela Parodi; Enrico Balleari; Federica Barbieri; Alessandra Pattarozzi; Tullio Florio; Silvano Ferrini; Giorgio Corte; Daniela de Totero
Journal:  Haematologica       Date:  2011-04-12       Impact factor: 9.941

Review 4.  Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa.

Authors:  Kabir A Khan; Robert S Kerbel
Journal:  Nat Rev Clin Oncol       Date:  2018-02-13       Impact factor: 66.675

5.  Identification of chimeric antigen receptors that mediate constitutive or inducible proliferation of T cells.

Authors:  Matthew J Frigault; Jihyun Lee; Maria Ciocca Basil; Carmine Carpenito; Shinichiro Motohashi; John Scholler; Omkar U Kawalekar; Sonia Guedan; Shannon E McGettigan; Avery D Posey; Sonny Ang; Laurence J N Cooper; Jesse M Platt; F Brad Johnson; Chrystal M Paulos; Yangbing Zhao; Michael Kalos; Michael C Milone; Carl H June
Journal:  Cancer Immunol Res       Date:  2015-01-19       Impact factor: 11.151

6.  Lymphocytes serve as a reservoir for Listeria monocytogenes growth during infection of mice.

Authors:  Denise S McElroy; Taylor J Ashley; Sarah E F D'Orazio
Journal:  Microb Pathog       Date:  2009-02-07       Impact factor: 3.738

7.  C-Met expression and mechanical activation of satellite cells on cultured muscle fibers.

Authors:  Ashley C Wozniak; Orest Pilipowicz; Zipora Yablonka-Reuveni; Steven Greenway; Shauna Craven; Elliott Scott; Judy E Anderson
Journal:  J Histochem Cytochem       Date:  2003-11       Impact factor: 2.479

8.  Association of hepatocyte-derived growth factor receptor/caudal type homeobox 2 co-expression with mucosal regeneration in active ulcerative colitis.

Authors:  Ferenc Sipos; Miklós Constantinovits; Gábor Valcz; Zsolt Tulassay; Györgyi Műzes
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

Review 9.  Preclinical and clinical evaluation of MET functions in cancer cells and in the tumor stroma.

Authors:  V Finisguerra; H Prenen; M Mazzone
Journal:  Oncogene       Date:  2016-03-21       Impact factor: 9.867

Review 10.  Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma.

Authors:  G Kapatai; P Murray
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.